Skip to main content
Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.500
-0.010 (-0.66%)
Apr 29, 2026, 3:03 PM EDT - Market open

Geron Revenue

In the year 2025, Geron had annual revenue of $183.88M with 138.83% growth. Geron had revenue of $48.02M in the quarter ending December 31, 2025, with 1.01% growth.

Revenue (ttm)
$183.88M
Revenue Growth
+138.83%
P/S Ratio
5.23
Revenue / Employee
$712,717
Employees
258
Market Cap
961.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025183.88M106.89M138.83%
Dec 31, 202476.99M76.76M32,386.92%
Dec 31, 2023237.00K-359.00K-60.23%
Dec 31, 2022596.00K-797.00K-57.21%
Dec 31, 20211.39M1.14M450.59%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.72B
Xeris Biopharma Holdings 291.85M
Maravai LifeSciences Holdings 185.74M
Phathom Pharmaceuticals 175.11M
Xencor 125.58M
CytomX Therapeutics 76.20M
KalVista Pharmaceuticals 73.62M
Janux Therapeutics 10.00M
Revenue Rankings

GERN News

More News